PIPR

MINNEAPOLIS, July 16, 2026--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, will release its second quarter 2026 financial results prior to the opening of the market on Thursday, July 30, 2026. The earnings release will be available at the company’s website at pipersandler.com/earnings. Chad Abraham, chairman and chief executive officer; Deb Schoneman, president; and Kate Clune, chief financial officer, will host a related conference call at 9:00 a.m. ET (8:00 a.m. CT) that same day to review the financial results. There will be a question and answer session following the review. Investors and analysts may participate in the live conference call by dialing 800 330-6710 (in the U.S.) or +1 312 471-1353 (outside the U.S.) and passcode 8969597. Please dial in at least 15 minutes prior to the call time. A live audio webcast of the conference call will be available through the company’s website at pipersandler.com/earnings. A replay of the conference call will be available after the event through the same link. Please direct any questions regarding obtaining access to the conference call to Piper Sandler Investor Relations, via email, at [email protected]. ABOUT PIPER SANDLER Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in the Abu Dhabi Global Market through Piper Sandler MENA Ltd., authorized and regulated by the ADGM Financial Services Regulatory Authority. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates. © 2026. Since 1895. Piper Sandler Companies. 350 North 5th Street, Suite 1000, Minneapolis, Minnesota 55401-5711 View source version on businesswire.com: https://www.businesswire.com/news/home/20260716323147/en/ Contacts Kate CluneTel: 212 [email protected]

Investing.com -- Piper Sandler defended its Overweight rating on Oracle in a note to clients on Monday, arguing the company could generate approximately $2.2 billion in Oracle Cloud Infrastructure revenue not currently captured in consensus estimates, based on the firm’s analysis of capital expenditure to data center capacity to revenue conversion. Analyst Billy Fitzsimmons said Oracle "has remained a controversial name" in Piper Sandler’s coverage, given ongoing concerns around capital requirements, AI monetization, customer concentration and margins. However, the firm is "constructive given our OCI analysis, accelerating revenue growth, the new CFO potentially being a more prudent guider, and reasonable expectations for the apps business in FY27." Using disclosures from Crusoe and CoreWeave as benchmarks, Piper Sandler estimated a baseline cost of approximately $46 million per megawatt and IaaS revenue of approximately $13.5 million per megawatt. Applying those assumptions to Oracle’s projected fiscal 2027 capital expenditure, the firm estimated approximately 2,400 megawatts of capacity could come online during the year. Based on that capacity ramping over the course of fiscal 2027, Piper Sandler calculated net new OCI revenue of approximately $23.0 billion, compared to its current estimate of $20.8 billion, implying total fiscal 2027 OCI revenue of $41.1 billion. Fitzsimmons described the potential incremental contribution as a "12% tailwind to FY27 OCI growth." Oracle shares have pulled back following fourth-quarter results, which Piper Sandler said present an opportunity given the upside scenario its analysis supports. Related articles Piper Sandler defends Oracle ahead of earnings, sees $2.2bn OCI revenue upside JPMorgan outlines ten strategic themes that could shape the outlook for 2026 This sector is 'poised for a big, beautiful year': Truist

The market is treading through uncertain times entering the third quarter, so Michael Kantrowitz of Piper Sandler thinks investors should look beyond just searching for the next winners. Enter Piper Sandler’s “Sell Model,” which aims to identify stocks to avoid in your portfolio, highlight risks, and find potential shorts.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at investment banking & brokerage stocks, starting with Piper Sandler (NYSE:PIPR). Investment banks and brokerages facilitate capital raises, mergers and acquisitions, and securities trading. The sector benefits from corporate activity during economic expansion, increased retail trading participation, and advisory opportunities in emerging sectors. Headwinds include economic cycle vulnerability affecting deal flow, compressed trading commissions due to electronic platforms, and regulatory capital requirements constraining certain higher-risk activities. The 15 investment banking & brokerage stocks we track reported a mixed Q1. As a group, revenues beat analysts’ consensus estimates by 0.8% while next quarter’s revenue guidance was in line. In light of this news, share prices of the companies have held steady. On average, they are relatively unchanged since the latest earnings results. Tracing its roots back to 1895 and rebranded from Piper Jaffray in 2020, Piper Sandler (NYSE:PIPR) is an investment bank that provides advisory services, capital raising, institutional brokerage, and research for corporations, governments, and institutional investors. Piper Sandler reported revenues of $469.5 million, up 22.5% year on year. This print exceeded analysts’ expectations by 8.2%. Overall, it was an exceptional quarter for the company with a solid beat of analysts’ revenue and EPS estimates. Investor expectations, however, were likely higher than Wall Street’s published projections, leaving some wishing for even better results (analysts’ consensus estimates are those published by big banks and advisory firms, not the investors who make buy and sell decisions). The stock is down 9.3% since reporting and currently trades at $79.11. Is now the time to buy Piper Sandler? Access our full analysis of the earnings results here, it’s free. Founded in 1995 as a boutique advisory firm focused on independence and client trust, Evercore (NYSE:EVR) is an independent investment banking firm that provides strategic advisory, capital markets, and wealth management services to corporations, financial sponsors, and high-net-worth individuals. Evercore reported revenues of $1.40 billion, up 100% year on year, outperforming analysts’...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Boot Barn Holdings just saw its fair value estimate trimmed from US$237.14 to US$225.14 per share, a small reset that still reflects a detailed refresh of the underlying valuation work. This shift lines up with Street research that mixes confidence in the latest Q4 execution and guidance with more caution on where the stock should trade right now. As you read on, you will see how these changing targets and narratives fit together and how to track the story as it evolves. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Boot Barn Holdings. UBS raised its price target to US$272, citing a solid Q4 report and an updated model that supports a higher valuation framework. Piper Sandler kept an Overweight rating, pointing to Q4 comparable sales upside and early Q1 comps up 5%, and describing FY27 guidance as appropriately conservative. BofA maintained a Buy rating after Q4 results that it viewed as in line with expectations, and argued that the stock looks too cheap relative to its growth profile. Baird kept an Outperform rating, stating that the updated model and the 2027 plan look reassuring following Q4 results. Williams Trading, Piper Sandler, Baird and BofA all cut price targets, reflecting a reset in what they are willing to pay for the stock even as they keep positive ratings. BofA explicitly trimmed its valuation multiple, pointing to a broader derating in consumer growth company multiples that weighs on where the stock might trade. Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives! See how Boot Barn Holdings' fair value stacks up across multiple valuation models — not just analyst targets. Boot Barn Holdings updated its buyback activity, repurchasing 68,472 shares, or 0.22% of shares, for US$12.5 million between December 28, 2025 and March 28, 2026, bringing total repurchases under the May 14, 2025 authorization to 286,504 shares, or 0.94%, for US$49.94 million. The company issued guidance for the first fiscal quarter ending June 27, 2026, with expected total sales of US$574 million to US$584 million, consolidated same store sales growth of 2% to 4%, and income from ope...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Community Healthcare Trust’s fair value price target is steady at US$18.50, with no change from the prior estimate, even as other model inputs have been refreshed. That stable target sits alongside analyst research that clusters expectations in the mid to high teens and weighs steady execution against funding and tenant risks. As you read on, you will see how these target assumptions fit into the evolving narrative around balance sheet choices, earnings resilience, and the planned asset sale. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Community Healthcare Trust. Truist maintains a Buy rating with a US$19 price target, highlighting expectations for moderate earnings growth and suggesting confidence in Community Healthcare Trust’s ability to keep earnings supported over time. Piper Sandler, with a Neutral rating and an US$18 price target, points to management’s focus on core operations and capital recycling while the company works through the planned sale of six geriatric behavioral hospitals. Evercore ISI raised its target to US$17 after what it described as a steady Q4, which aligns with the view that execution has been consistent even as the portfolio is being repositioned. Truist flags rising leverage as a concern and notes that Community Healthcare Trust could benefit from a lower cost of equity, which ties directly into how easily it can fund growth and support its balance sheet. Piper Sandler highlights ongoing issues with a troubled tenant and the pending sale of six hospitals across three states, underscoring transaction and counterparty risk while the buyer completes final due diligence. Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives! We've flagged 3 risks for Community Healthcare Trust. See which could impact your investment. Community Healthcare Trust declared a quarterly dividend of US$0.4800 per share, with payment scheduled for May 22, 2026. This may interest income focused investors watching near term cash flows. The dividend carries an ex date of May 11, 2026. Investors buying the stock on or after that day would no...

Investing.com -- Piper Sandler upgraded Deckers Outdoor Corporation to “Neutral” from “Underweight,” saying the recent pullback in the stock has created a more balanced risk-reward profile ahead of the company’s fiscal fourth-quarter earnings report on May 21. The brokerage raised its price target on the footwear maker to $100 from $95, implying modest upside from the stock’s recent close of $93.56. Analysts said the shares now trade at roughly 13 times expected fiscal 2027 earnings, a valuation they view as reasonable given improving investor sentiment expectations and the potential for earnings upside. Piper Sandler expects Deckers to beat consensus expectations for the fiscal fourth quarter, forecasting earnings per share of about $1.00 compared with Wall Street estimates of $0.83. The firm projects revenue growth of 8%, above the company’s guidance of around 5% and ahead of consensus expectations of 6%. The analysts pointed to stronger direct-to-consumer performance at both the UGG and HOKA brands, supported by easier comparisons and reduced promotional activity. For HOKA, Piper expects direct-to-consumer sales growth of roughly 20%, helped by momentum in updated franchise models such as Speedgoat 7 and Gaviota 6. Despite the upgrade, Piper Sandler maintained a cautious view on the broader sneaker category, warning that lifestyle running trends are moderating amid intensifying competition. The analysts also said HOKA still lacks sufficient diversification beyond its popular max-cushioning footwear lineup. The firm said it continues to prefer On Holding AG within the global athletic footwear sector due to its stronger growth profile. Piper reiterated its “Overweight” rating on On Holding with a $50 price target. Looking ahead, Piper Sandler expects Deckers’ fiscal 2027 sales guidance to align with Street forecasts of roughly 7% growth, with HOKA expected to post low- to mid-teen percentage growth and UGG growing in the low- to mid-single digits. The brokerage also highlighted the company’s strong balance sheet, noting more than $2 billion in cash and $1.7 billion remaining under its share repurchase authorization. Related articles Piper sees earnings beat potential for Deckers Outdoor Corporation Nvidia's new Alpamayo project: What it means for Tesla? 5 reasons why Jefferies thinks Meta’s pullback is a buying opportunity

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Piper Sandler’s latest commentary on Aflac (AFL) followed quarterly earnings that came in below estimates, with weaker pre tax margins in Aflac Japan and two consecutive quarters of segment earnings pressure. See our latest analysis for Aflac. The recent earnings miss and softer Aflac Japan margins have not derailed the stock entirely, with a 30 day share price return of 4.93% and a 1 year total shareholder return of 12.99%, which suggests that momentum is still broadly positive over time. If this mix of earnings pressure and long term compounding has you thinking about diversification, it could be a good moment to size up 20 top founder-led companies With the stock trading at $116.16, sitting slightly above the average analyst price target yet showing a value score of 3 and an estimated 31% intrinsic discount, you have to ask: is Aflac undervalued, or is the market already pricing in future growth? The most followed narrative pegs Aflac’s fair value at $111.86, slightly below the $116.16 last close. This frames the stock as marginally ahead of that model. Net profit margin: The net profit margin input has nudged higher from 20.75% to 20.86%, pointing to slightly stronger expected profitability on each dollar of revenue. Read the complete narrative. Want to see what keeps earnings expectations firm even as revenue assumptions cool and future P/E rises above the sector? The narrative’s valuation hinges on that balance. Result: Fair Value of $111.86 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there are still pressure points, including declining net earned premiums in Japan and weaker variable investment income, that could challenge this more optimistic valuation story. Find out about the key risks to this Aflac narrative. While the popular narrative calls Aflac about 4% overvalued at $111.86, the SWS DCF model paints a very different picture. On that framework, the stock at $116.16 trades around 31% below an estimated fair value of $167.92. This raises a key question: are earnings based multiples missing something in Aflac's long term cash generation story? Look into how the SWS DCF model arrives at its fair value. Simply Wall St performs a discounted cash flow (DCF) on every stock in the world e...

CF Bankshares Inc. (NASDAQ:CFBK) is included among the 12 Best Micro-Cap Dividend Stocks to Buy Now. On May 11, Piper Sandler analyst Adam Kroll lowered the firm’s price target on CF Bankshares Inc. (NASDAQ:CFBK) to $33.50 from $34 and maintained an Overweight rating on the shares. The firm said the company reported a mixed quarter. An increase in non-performing loans tied to one non-core relationship led to $0.5 million in interest reversals and contributed to the shortfall in PPNR and EPS results. Earlier in April, Piper Sandler initiated coverage on CF Bankshares with an Overweight rating and a $34 price target, up from $29.The firm said the company’s turnaround following its 2012 recapitalization had been “nothing short of impressive.” Piper also pointed to CF Bankshares’ stronger-than-peer organic balance sheet growth outlook, along with expectations for modest net interest margin expansion that could support additional profitability improvement toward peer levels. The analyst also highlighted the company’s relatively discounted valuation. CF Bankshares Inc. (NASDAQ:CFBK) is the holding company for CFBank, National Association. CFBank operates as a commercial bank across five major metro markets, including Columbus, Cleveland, Cincinnati, and Akron, Ohio, along with Indianapolis, Indiana. The bank provides commercial, retail, and mortgage lending services to businesses and entrepreneurs. While we acknowledge the potential of CFBK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Best Dividend Stocks to Buy for Steady Growth and 10 Best Robinhood Stocks to Buy According to Billionaires. Disclosure: None. Follow Insider Monkey on Google News.

Record Q1 results: Piper Sandler reported adjusted net revenues of $470 million (its 10th consecutive quarter of YoY growth), a 20% operating margin and adjusted diluted EPS of $1, with adjusted net income of $72 million and operating income of $94 million. Investment banking and advisory led by healthcare and financial services: Corporate investment banking revenues were a first-quarter record of $324 million (up 30% YoY) and advisory revenues hit a record $251 million (up 16% YoY), with the firm ranking top in U.S. MedTech M&A and bank M&A value; management cautioned Q2 may not match the quarter’s surge and expects corporate financing and some market-share gains to ease. Capital returns and charges: The firm raised $14 billion across 36 financings and returned $171 million to shareholders (including $101 million in dividends and $70 million in buybacks), announced a 14% increase to the quarterly dividend and a 4-for-1 forward stock split, while recording an $8.5 million litigation-related expense. Interested in Piper Sandler Companies? Here are five stocks we like better. CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens? Piper Sandler Companies (NYSE:PIPR) opened fiscal 2026 with what management called a “strong start to the year,” driven by record first-quarter results in corporate investment banking and advisory, alongside record equity brokerage revenues. Chairman and CEO Chad Abraham said the firm generated first-quarter adjusted net revenues of $470 million, marking its “10th consecutive quarter of year-over-year growth,” with a 20% operating margin and adjusted diluted EPS of $1. CFO Kate Clune reported adjusted net income of $72 million and operating income of $94 million. → Meta Posted Its Best Sales Growth Since 2021—So Why Did Shares Fall? Kinder Morgan Stock Bid Up In An Oil Breakout Abraham said corporate investment banking delivered a first-quarter record, with revenues of $324 million, up 30% year-over-year. The increase was attributed to “robust corporate financing activity” and “solid contributions across advisory services.” Healthcare was a key driver. Abraham said the firm’s healthcare franchise produced an “exceptionally strong quarter,” reaching a “new high watermark in terms of revenues,” led by MedTech and biopharma, with additional contributions from healthcare IT and services. He noted that Piper Sandler ranked as the t...

Achieved a tenth consecutive quarter of year-over-year revenue growth, driven by a 30% increase in Corporate Investment Banking activity. Healthcare franchise reached a record revenue high-water mark, supported by strategic investments in Healthcare IT and Services alongside core medtech and biopharma strength. Maintained leadership in mid-market M&A, ranking as the #2 adviser for U.S. deals under $2 billion and #1 in U.S. bank M&A by deal value. Equity underwriting performance was characterized by significant market share gains in biopharma, where the firm's Healthcare team served as bookrunner on all 23 equity deals they priced during the quarter. Operating margin expanded to 20% as operating income growth of 37% significantly outpaced the 22% increase in net revenues. Strategic focus on non-M&A advisory, particularly Debt Capital Markets, provided a meaningful growth engine and diversified the advisory revenue stream. Talent expansion reached a record 192 investment banking managing directors, balancing internal promotions with strategic external hires in high-growth sectors. Management expects second quarter advisory revenues to remain similar to first quarter levels, reflecting a balance between strong pipelines and cautious market timing. Corporate financing revenues are projected to decline in the second quarter following an exceptionally strong first quarter characterized by outsized market share in biopharma. Public Finance revenues are anticipated to improve modestly in the second quarter, aligning with historical seasonal patterns for the municipal business. While Equity Brokerage and Fixed Income outlooks are influenced by market volatility and geopolitical events, Equity Brokerage revenues are specifically expected to decline in the second quarter from record Q1 levels. The firm intends to maintain a compensation ratio at the low end of the 61.5% to 62.5% range while continuing to seek additive investment opportunities. Recorded an $8.5 million litigation-related expense concerning a 2014 California lawsuit regarding variable rate demand notes in the Municipal Finance business. Completed a 4-for-1 forward stock split in March 2026, with common stock trading on a split-adjusted basis starting March 24. Increased the quarterly cash dividend by 14% to $0.20 per share, reflecting confidence in the firm's capital-light model and cash generation capab...

This article first appeared on GuruFocus. Adjusted Net Revenues: $470 million, marking the 10th consecutive quarter of year-over-year growth. Operating Margin: 20% for the first quarter. Adjusted EPS: $1 per share. Corporate Investment Banking Revenues: $324 million, up 30% year-over-year. Advisory Revenues: $251 million, up 16% year-over-year. Corporate Financing Revenues: $73 million, up 122% from the first quarter of last year. Municipal Financing Revenues: $24 million, down 9% year-over-year. Equity Brokerage Revenues: $60 million, an 11% increase from the prior year. Fixed Income Revenues: $50 million, up 6% from the prior year period. Net Income: $72 million for the first quarter. Compensation Ratio: 61.6%, an improvement of 90 basis points from the first quarter of last year. Non-Compensation Expenses: $86 million, up 15% year-over-year. Income Tax Rate: Effective tax rate of 23.4% with tax benefits; 30.8% excluding benefits. Shareholder Returns: $171 million returned, including $101 million in dividends and $70 million in share repurchases. Quarterly Cash Dividend: Increased to $0.20 per share, a 14% increase. Warning! GuruFocus has detected 2 Warning Sign with CNK. Is PIPR fairly valued? Test your thesis with our free DCF calculator. Release Date: May 01, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Piper Sandler Cos (NYSE:PIPR) achieved a record first quarter with adjusted net revenues of $470 million, marking the 10th consecutive quarter of year-over-year growth. Corporate Investment Banking revenues reached a first-quarter record of $324 million, up 30% year-over-year, driven by robust corporate financing activity. The Healthcare franchise set a new high watermark in revenues, with significant contributions from medtech and biopharma teams. The Financial Services group registered a strong quarter, ranking as the number one adviser in US bank M&A based on deal value announced. Equity Brokerage business achieved record first-quarter revenues of $60 million, an 11% increase from the prior year, driven by increased trading volumes. Municipal Financing revenues declined by 9% year-over-year, reflecting challenges in the public finance business. Fixed income revenues faced challenges due to high market volatility, which reduced regular client activity. Corporate Financing revenues are expecte...